CCC
JAZZ icon

Chesapeake Capital Corp’s Jazz Pharmaceuticals JAZZ Stock Holding History

Chesapeake Capital Corp’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$376K Buy
+3,051
New +$360K 0.38% 113

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Chesapeake Capital Corp's JAZZ Position: Q4 2024 in Review

Chesapeake Capital Corp opened a new position in Jazz Pharmaceuticals (JAZZ) in Q4 2024: 3,051 shares worth $376K. The stake represents 0.38% of the portfolio and ranks #113 among its holdings.

508 funds tracked by Wall St. Rank hold JAZZ as of Q4 2024.

  • Chesapeake Capital Corp held 3,051 shares of Jazz Pharmaceuticals worth $376K as of Q4 2024.
  • Jazz Pharmaceuticals was a new Chesapeake Capital Corp position in Q4 2024.
  • Jazz Pharmaceuticals made up 0.38% of Chesapeake Capital Corp's portfolio in Q4 2024, its #113 holding.
  • 508 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2024.

Based on Chesapeake Capital Corp's 13F filing for Q4 2024, filed 11 Feb 2025.